
💉 Developing medical countermeasures takes time and investment. Through #HERAInvest, the @EU_Commission supports companies developing solutions against priority cross-border health threats.
✓French Biotech developing breakthrough immunotherapies to address situations of emergency

💉 Developing medical countermeasures takes time and investment. Through #HERAInvest, the @EU_Commission supports companies developing solutions against priority cross-border health threats.

A valuable implementation dialogue on the EU Medical Countermeasures Strategy with industry, civil society, healthcare professionals, patient groups, academia and other key partners. Their insights will help strengthen Europe’s preparedness for future health emergencies

↪️ Fabentech démarre la livraison de ses premières doses pour les armées et l’export 🇪🇺, avec le soutien de la DGA via le dispositif régime d’appui à l’innovation duale pour les PME #RAPID

Merci Madame la Ministre @CaVautrin pour votre soutien. Cette réussite illustre la force du partenariat public-privé au service de l’intérêt général, fondé sur la confiance, l’excellence scientifique et l’engagement des armées aux côtés de l’innovation française.

Lire le communiqué : fabentech.com/fabentech-obti…

Information médias & investisseurs Obtention de l’AMM pour Ricimed®, premier antidote autorisé contre l’intoxication à la ricine — une menace biologique majeure. Ce jalon renforce le positionnement de Fabentech comme acteur européen de référence en contremesures médicales.

🎙️Sébastien IVA était invité sur le plateau de @BFMLyon à l’occasion de l’obtention d’un financement de 20 millions d’euros accordé par la Banque Européenne d’Investissement, via le mécanisme HERA Invest. @EIB @EC_HERA 👇👇 Replay à 2min41 lnkd.in/dnbvWjyA

Nous signons aujourd'hui via @EC_HERA & @EIB un accord HERA Invest d'une valeur de 20 M€ avec @Fabentech 🇫🇷 Il permettra à l'entreprise de mettre au point & déployer ses médicaments à large spectre afin de lutter contre les menaces biologiques pour la santé publique 🔬

🇫🇷🇪🇺 Investing in innovative biotech companies is essential to strengthen health security in Europe. We are joining forces with @EC_HERA and French biopharmaceutical company @fabentech to advance preparedness against pandemics and biological threats⤵️ bit.ly/Fabentech

1st #HERAInvest Ioan signed with @fabentech & @EIB to advance the development of broad-spectrum therapeutics against cross-border health threats. A vital step in fostering innovation & preparedness for public health emergencies with a €20M investment ➡️🔗europa.eu/!78TRDb


📢@Fabentech is thrilled to announce it will receive €20 million in financing to advance #Preparedness against #BiologicalThreats, allocated by the European Investment Bank @EIB through the @EC_HERA Invest programme! Read our press release at fabentech.com/en/french-biop…

🎙️Great presentation of Caroline Ballet at the 6th Edition of the #WorldCongressOnInfectiousDiseases! Caroline took the stage and shared the findings of Epic Crown 2 project. These results demonstrate the broadly neutralizing activity of #polyclonalantibody fragments.

📢 Great achievement! Fabentech is thrilled to announce the launch and first results of first-in-human clinical trial for a antidote against a deadly plant-based toxin! 🔎To discover more about this exciting news, visit our linkedin post 👇: linkedin.com/posts/fab%27ent…

Great discussion on health preparedness at @NATO HQ today! Head of HERA @LaurentMuschel had a productive exchange with NATO officials. A pleasure to see Dr Raed Arafat again! Together, we're better prepared to tackle global health challenges #NATO #HealthPreparedness #HERA

🤝 Ready to connect and discover more about Fabentech lifesaving solutions against biological threats? Come and meet Sébastien IVA, CEO, and Grégory Vernier, Ph.D., Head of Business Development, who will attend the BIO International Convention in San Diego from June 3th to 6th!